Use of benzimidazole chemotherapy in human helminthiases: indications and efficacy

Abstract

The past two decades have seen some remarkable developments in anthelmintic chemotherapy in clinical medicine. Whereas praziquantel has revolutionized the management of many cestode and trematode infections, Gordon Cook explains how the introduction of the benzimidazoles - most importantly thiabendazole, mebendazole and recently albendazole (flubendazole, cambendazole, ciclobendazole, and triclabendazole have also been used on a very limited scale) - has had a major impact upon the safe and effective management of several important intestinal and systemic nematode and, to a leser extent, cestode infections.